BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4916084)

  • 61. [Initial experience with ethinyl estradiol sulfonate (J 96) in the therapy of prostate carcinoma].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1979 Mar; 72(3):153-7. PubMed ID: 380227
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Management of prostate carcinoma.
    Whitehead ED
    N Y State J Med; 1981 Sep; 81(10):1481-5. PubMed ID: 7024862
    [No Abstract]   [Full Text] [Related]  

  • 63. The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review.
    Blackard CE
    Cancer Chemother Rep; 1975; 59(1):225-7. PubMed ID: 1093670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prostate cancer: non-metastatic.
    Wilt T
    Clin Evid; 2002 Jun; (7):812-23. PubMed ID: 12230707
    [No Abstract]   [Full Text] [Related]  

  • 65. [Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
    Carstensen HE; Olsen CE; Sele V; Brorson I; Jensen E; Nissen NI; Fabricius J
    Nord Med; 1969 Jan; 81(4):111-4. PubMed ID: 4888811
    [No Abstract]   [Full Text] [Related]  

  • 66. Cancer of the prostate in Oslo 1958-1967.
    Fryjordet A; Ekeland A; Moe A; Ous S; Waaler G
    J Oslo City Hosp; 1973 Aug; 23(8):129-37. PubMed ID: 4767717
    [No Abstract]   [Full Text] [Related]  

  • 67. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S; Johnson R
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract]   [Full Text] [Related]  

  • 68. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H; Katayose K; Kumakawa K; Shiraiwa Y; Uchida H; Takahashi Y; Yazaki J; Yamaguchi O
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):57-63. PubMed ID: 15675583
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunomodulatory effects of oestrogen in prostatic cancer: update and further consideration.
    Ablin RJ
    Allergol Immunopathol (Madr); 1981; 9(1):63-70. PubMed ID: 7258047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of stage 1 carcinoma of the prostate: a preliminary report.
    Blackard CE; Mellinger GT; Gleason DF
    J Urol; 1971 Nov; 106(5):729-33. PubMed ID: 5115730
    [No Abstract]   [Full Text] [Related]  

  • 71. Comparison of treatments for prostatic cancer using an exponential-type life model relating survival to concomitant information.
    Bayard S; Greenberg R; Showalter D; Byar D
    Cancer Chemother Rep; 1974; 58(6):845-59. PubMed ID: 4447926
    [No Abstract]   [Full Text] [Related]  

  • 72. [Observations on the prognosis of conservatively treated prostatic neoplasm].
    Hasselbacher K; Heinrichs H
    Z Urol Nephrol; 1974 Mar; 67(3):161-4. PubMed ID: 4849272
    [No Abstract]   [Full Text] [Related]  

  • 73. [Resorption and effectiveness of implanted compressed hormones in carcinoma of the prostate].
    Ziesche HW
    Urol Int; 1965; 20(5):289-304. PubMed ID: 5863979
    [No Abstract]   [Full Text] [Related]  

  • 74. Treatment of prostatic carcinoma with Stilbostat.
    Zimel H; Bocancea D
    Neoplasma; 1974; 21(1):101-8. PubMed ID: 4596007
    [No Abstract]   [Full Text] [Related]  

  • 75. [Endocrine therapy of prostatic cancer].
    Shimazaki J; Fuse H; Zama S
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1195-201. PubMed ID: 4057576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of prostatic cancer: studies by the Veterans Administration cooperative urological research group.
    Byar DP
    Bull N Y Acad Med; 1972 Jun; 48(5):751-66. PubMed ID: 4555718
    [No Abstract]   [Full Text] [Related]  

  • 77. Intraductal carcinoma of the prostate gland.
    Rhamy RK; Buchanan RD; Spalding MJ
    Trans Am Assoc Genitourin Surg; 1972; 64():61-8. PubMed ID: 4654524
    [No Abstract]   [Full Text] [Related]  

  • 78. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Curative radiotherapy in stage C prostatic carcinoma. Experiences with radiotherapy-endocrine treatment].
    Klosterhalfen H; Becker H; Köllermann MW; Altenähr E
    Urologe A; 1983 Sep; 22 Suppl():360-6. PubMed ID: 6314624
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Hormonal therapy of prostatic carcinoma].
    Martz G
    Internist (Berl); 1968 Sep; 9(9):375-80. PubMed ID: 4918657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.